Katy Moffat

Group Leader, Flow Cytometry & Cell Sorting Facility at The Pirbright Institute

Katy Moffat studied for her BSc Hons in Biochemistry at Stirling University and then completed her PhD at the John Innes centre, studying the effects of gene silencing on virus infection in plants. She joined the Immunology group at The Pirbright Institute in 2001 to examine interactions between foot-and-mouth disease virus (FMDV) and intracellular proteins during virus replication.

Katy discovered that FMDV infection lead to a disruption of the cellular protein secretory pathway and the viral protein responsible differed to that of another picornavirus, Poliovirus. In 2006, Katy became part of the Vaccinology group and is currently studying responses of dendritic cells (immune cells) to bluetongue virus (BTV) infection.

Location

England, United Kingdom

Links


Org chart

No direct reports

Teams


Offices

This person is not in any offices


The Pirbright Institute

The Pirbright Institute is a world leading centre of excellence in research and surveillance of virus diseases of farm animals and viruses that spread from animals to humans. Working to enhance capability to contain, control and eliminate these economically and medically important diseases, the Institute's highly innovative fundamental and applied bioscience contributes to global food security and health, improving quality of life for animals and people.


Industries

Employees

201-500

Links